パチスロセクシー女優

Top
パチスロセクシー女優
パチスロセクシー女優K. receives manufacturing and marketing approval of LYFNUA® Tablets, world's first selective P2X3 receptor antagonist for the treatment of chronic cough

パチスロセクシー女優K. receives manufacturing and marketing approval of LYFNUA® Tablets, world's first selective P2X3 receptor antagonist for the treatment of chronic cough

January 20, 2022

Please see the PDF file below for details.

パチスロセクシー女優K. receives manufacturing and marketing approval of LYFNUA® Tablets, world's first selective P2X3 receptor antagonist for the treatment of chronic cough [ 105.4 KB ]